Fibroblast-growth factor 23 (FGF23)-associated hypophosphatemic rickets was historically treated with frequent doses of oral phosphate salts in combination with active vitamin D—so-called conventional treatment [9, 14, 15]. Here, FGF23 is linked to Dent disease.